Basic Information
Capricor Therapeutics is a biotechnology company focused on the discovery, development, and commercialization of first-class therapeutic drugs. As a developer of innovative therapies, Capricor Therapeutics is strategically positioned at the forefront of one of the largest sectors in the U.S. healthcare industry—cardiovascular diseases. The primary product targets of Capricor Therapeutics are the prevention and treatment of heart failure and "myocardial infarction."
Capricor Therapeutics Inc.
California,United States of America
15~50 people
January 01, 2005
info@capricor.com

